Orphan medicines: the high cost of hope

Publisher： John Wiley & Sons Inc

E-ISSN： 1931-2253|29|1|23-27

ISSN： 0959-6682

Source： PRESCRIBER, Vol.29, Iss.1, 2018-01, pp. : 23-27

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

What is known about the cost‐effectiveness of orphan drugs? Evidence from cost‐utility analyses

By  

JOURNAL OF CLINICAL PHARMACY & THERAPEUTICS, Vol. 40, Iss. 3, 2015-06 ,pp. : 304-307

John Wiley & Sons Inc

Access to resources Recommend Favorite

Medicines

By  

Clio Medica/The Wellcome Series in the History of Medicine, Vol. 89, Iss. 1, 2011-02 ,pp. : 233-289

Rodopi

Access to resources Recommend Favorite

Is the Cost of Transporting Equipment too High?

By Woolloff Jennifer  

The British Journal of Occupational Therapy, Vol. 66, Iss. 1, 2003-01 ,pp. : 31-32

College of Occupational Therapists

Access to resources Recommend Favorite

High Cost Patients and the Consortium Approach

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 32, Iss. 1, 2002-05 ,pp. : 26-28

Karger

Access to resources Recommend Favorite

COST AND ACQUISITION OF PRESCRIBED AND NONPRESCRIBED MEDICINES, UNITED STATES, JULY 1964–JUNE 1965

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 15, Iss. 4, 1967-04 ,pp. : 403-404

John Wiley & Sons Inc

Access to resources Recommend Favorite